Kelli Whitlock Burton July 30, 2025 The FDA is recommending that 7-hydroxymitragynine (7-OH), a synthetic, concentrated substance
Kelli Whitlock Burton is a Neurology and Psychiatry Reporter at Medscape. With over 25 years of experience as a science writer and editor, she specializes in topics such as mental health care, psychiatry, and aging & longevity, often drawing connections between these areas. Kelli's work has been featured in MDEdge and Medscape, showcasing her expertise in hematology and pathology as well.



